Total Payments
$8,565
2024 Payments
$496.71
Companies
43
Transactions
450
Medicare Patients
2,007
Medicare Billing
$228,974
Payment Breakdown by Category
Food & Beverage$8,546 (99.8%)
Education$19.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,546 | 448 | 99.8% |
| Education | $19.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,597 | 79 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,344 | 74 | $0 (2024) |
| Philips Electronics North America Corporation | $840.87 | 55 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $746.62 | 41 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $466.10 | 42 | $0 (2024) |
| GENZYME CORPORATION | $312.05 | 16 | $0 (2024) |
| Advanced Respiratory, Inc | $289.99 | 12 | $0 (2021) |
| Mylan Specialty L.P. | $213.72 | 10 | $0 (2024) |
| Grifols USA, LLC | $199.20 | 9 | $0 (2023) |
| Genentech USA, Inc. | $186.45 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $496.71 | 28 | GlaxoSmithKline, LLC. ($159.53) |
| 2023 | $696.05 | 38 | GlaxoSmithKline, LLC. ($172.85) |
| 2022 | $631.57 | 30 | GlaxoSmithKline, LLC. ($140.92) |
| 2021 | $1,237 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($295.93) |
| 2020 | $1,382 | 75 | GlaxoSmithKline, LLC. ($336.75) |
| 2019 | $2,336 | 114 | Boehringer Ingelheim Pharmaceuticals, Inc. ($435.94) |
| 2018 | $1,675 | 101 | Philips Electronics North America Corporation ($409.48) |
| 2017 | $110.15 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($110.15) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiology | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 05/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Immunology | ||||||
| 03/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 413 | 540 | $176,676 | $44,983 |
| 2022 | 9 | 404 | 561 | $145,519 | $47,889 |
| 2021 | 9 | 554 | 697 | $184,522 | $61,190 |
| 2020 | 10 | 636 | 898 | $207,189 | $74,912 |
Total Patients
2,007
Total Services
2,696
Medicare Billing
$228,974
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 294 | $115,313 | $29,425 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $26,555 | $6,440 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 40 | $10,878 | $2,951 | 27.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 40 | 42 | $8,046 | $2,122 | 26.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 40 | 42 | $7,635 | $2,016 | 26.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 25 | 25 | $3,559 | $834.72 | 23.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 21 | 25 | $2,676 | $665.85 | 24.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 20 | 22 | $2,014 | $528.88 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 309 | $90,701 | $31,354 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $18,488 | $4,973 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 48 | $9,732 | $3,343 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $5,900 | $2,328 | 39.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 41 | 43 | $6,858 | $2,182 | 31.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 40 | 42 | $6,329 | $1,990 | 31.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 26 | 27 | $4,494 | $851.40 | 18.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 18 | 19 | $1,558 | $434.84 | 27.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 15 | 16 | $1,459 | $433.20 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 205 | 334 | $98,039 | $34,557 | 35.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 75 | 75 | $33,014 | $9,582 | 29.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 47 | 56 | $16,438 | $5,520 | 33.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 45 | $9,124 | $3,154 | 34.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 58 | 58 | $9,250 | $3,051 | 33.0% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 57 | 57 | $8,590 | $2,785 | 32.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 48 | 48 | $7,990 | $1,900 | 23.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 12 | 12 | $984.00 | $320.04 | 32.5% |
About Dr. William Hooper, MD
Dr. William Hooper, MD is a Pulmonary Disease healthcare provider based in Encinitas, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720052988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Hooper, MD has received a total of $8,565 in payments from pharmaceutical and medical device companies, with $496.71 received in 2024. These payments were reported across 450 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,546).
As a Medicare-enrolled provider, Hooper has provided services to 2,007 Medicare beneficiaries, totaling 2,696 services with total Medicare billing of $228,974. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Encinitas, CA
- Active Since 02/15/2006
- Last Updated 10/09/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1720052988
Products in Payments
- OFEV (Drug) $729.52
- STIOLTO RESPIMAT (Drug) $578.41
- TRELEGY ELLIPTA (Drug) $501.77
- DUPIXENT (Biological) $449.49
- Respiratoriy Care Undiv (Device) $304.46
- NUCALA (Biological) $269.81
- ANORO ELLIPTA (Drug) $248.44
- UPTRAVI (Drug) $228.88
- SYMBICORT (Drug) $226.98
- ANORO (Drug) $206.54
- (8876) Vest Therapy Und (Device) $200.27
- Prolastin-C Liquid (Biological) $199.20
- Otezla (Drug) $181.57
- LONHALA MAGNAIR (Drug) $176.43
- Xolair (Biological) $171.34
- OPSUMIT MACITENTAN (Drug) $164.69
- Yupelri (Drug) $153.80
- Life 2000 Ventilation System (Device) $149.86
- The Vest System Model 105 Home Care (Device) $140.13
- FASENRA (Drug) $128.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Encinitas
Alejandro Pino, Md, MD
Pulmonary Disease — Payments: $6,364
Pulmonary Disease $6,364
Dr. Robert Savage, M.d, M.D
Pulmonary Disease — Payments: $1,581
Pulmonary Disease $1,581
Alisha Kabadi, Md, MD
Pulmonary Disease — Payments: $389.92
Pulmonary Disease $389.92
Dr. Dennis Amundson, Do, DO
Pulmonary Disease — Payments: $279.31
Pulmonary Disease $279.31
Christina Cheng
Pulmonary Disease
Pulmonary Disease
Hannah Robertson, Md, MD
Pulmonary Disease
Pulmonary Disease